ReP USP - Resultado da busca

Artigo de periodico
IGF1R/IRS1 targeting has cytotoxic activity and inhibits PI3K/AKT/mTOR and MAPK signaling in acute lymphoblastic leukemia cells (2019)
Alves, Ana Paula Nunes Rodrigues; Fernandes, Jaqueline Cristina; Fenerich, Bruna Alves ; Silva, Juan Luiz Coelho da; Scheucher, Priscila Santos ; Simões, Belinda Pinto ; Rego, Eduardo Magalhaes ; Ridley, Anne J. ; Machado Neto, João Agostinho ; Traina, Fabiola
Source: Cancer Letters. Unidades: FMRP, FM, ICB
Subjects: LEUCEMIA, CÉLULAS SANGUINEAS, CITOTOXINAS, APOPTOSE, CÉLULAS CULTIVADAS DE TUMOR, ONCOGENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Ana Paula Nunes Rodrigues et al. IGF1R/IRS1 targeting has cytotoxic activity and inhibits PI3K/AKT/mTOR and MAPK signaling in acute lymphoblastic leukemia cells. Cancer Letters, v. 456, p. 59-68, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.canlet.2019.04.030. Acesso em: 06 nov. 2024.
APA
Alves, A. P. N. R., Fernandes, J. C., Fenerich, B. A., Silva, J. L. C. da, Scheucher, P. S., Simões, B. P., et al. (2019). IGF1R/IRS1 targeting has cytotoxic activity and inhibits PI3K/AKT/mTOR and MAPK signaling in acute lymphoblastic leukemia cells. Cancer Letters, 456, 59-68. doi:10.1016/j.canlet.2019.04.030
NLM
Alves APNR, Fernandes JC, Fenerich BA, Silva JLC da, Scheucher PS, Simões BP, Rego EM, Ridley AJ, Machado Neto JA, Traina F. IGF1R/IRS1 targeting has cytotoxic activity and inhibits PI3K/AKT/mTOR and MAPK signaling in acute lymphoblastic leukemia cells [Internet]. Cancer Letters. 2019 ; 456 59-68.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.canlet.2019.04.030
Vancouver
Alves APNR, Fernandes JC, Fenerich BA, Silva JLC da, Scheucher PS, Simões BP, Rego EM, Ridley AJ, Machado Neto JA, Traina F. IGF1R/IRS1 targeting has cytotoxic activity and inhibits PI3K/AKT/mTOR and MAPK signaling in acute lymphoblastic leukemia cells [Internet]. Cancer Letters. 2019 ; 456 59-68.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.canlet.2019.04.030
Artigo de periodico
Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells (2019)
Donaires, Flávia Sacilotto ; Paiva, Raquel de Melo Alves; Gutierrez-Rodrigues, Fernanda ; Silva, Fernanda Borges da; Tellechea, Maria Florencia; Moreira, Lílian Figueiredo; Santana, Bárbara Amélia Aparecida; Traina, Fabiola ; Dunbar, Cynthia E.; Winkler, Thomas; Calado, Rodrigo Tocantins
Source: Stem Cell Research. Unidade: FMRP
Subjects: TELÔMERO, CÉLULAS, MUTAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DONAIRES, Flávia Sacilotto et al. Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells. Stem Cell Research, v. 40, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.scr.2019.101540. Acesso em: 06 nov. 2024.
APA
Donaires, F. S., Paiva, R. de M. A., Gutierrez-Rodrigues, F., Silva, F. B. da, Tellechea, M. F., Moreira, L. F., et al. (2019). Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells. Stem Cell Research, 40. doi:10.1016/j.scr.2019.101540
NLM
Donaires FS, Paiva R de MA, Gutierrez-Rodrigues F, Silva FB da, Tellechea MF, Moreira LF, Santana BAA, Traina F, Dunbar CE, Winkler T, Calado RT. Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells [Internet]. Stem Cell Research. 2019 ; 40[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.scr.2019.101540
Vancouver
Donaires FS, Paiva R de MA, Gutierrez-Rodrigues F, Silva FB da, Tellechea MF, Moreira LF, Santana BAA, Traina F, Dunbar CE, Winkler T, Calado RT. Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells [Internet]. Stem Cell Research. 2019 ; 40[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.scr.2019.101540
Artigo de periodico
PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia (2019)
Lima, Keli Cristina de ; Silva, Juan Luiz Coelho da ; Kinker, Gabriela Sarti ; Pereira-Martins, Diego Antonio; Traina, Fabiola ; Fernandes, Pedro Augusto Carlos Magno ; Markus, Regina P ; Lucena-Araújo, Antonio Roberto Lucena; Machado Neto, João Agostinho
Source: Cancer Genetics. Unidades: FMRP, IB, ICB, FM
Subjects: LEUCEMIA MIELOIDE, LIPÍDEOS, CITOGENÉTICA, PROTEÍNAS QUINASES, LIPÍDEOS, TRANSCRIÇÃO GÊNICA, MICRORNAS, EXPRESSÃO GÊNICA, RNA, GENÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli Cristina de et al. PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia. Cancer Genetics, v. 233-234, p. 56-66, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.cancergen.2019.04.002. Acesso em: 06 nov. 2024.
APA
Lima, K. C. de, Silva, J. L. C. da, Kinker, G. S., Pereira-Martins, D. A., Traina, F., Fernandes, P. A. C. M., et al. (2019). PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia. Cancer Genetics, 233-234, 56-66. doi:10.1016/j.cancergen.2019.04.002
NLM
Lima KC de, Silva JLC da, Kinker GS, Pereira-Martins DA, Traina F, Fernandes PACM, Markus RP, Lucena-Araújo ARL, Machado Neto JA. PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia [Internet]. Cancer Genetics. 2019 ; 233-234 56-66.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cancergen.2019.04.002
Vancouver
Lima KC de, Silva JLC da, Kinker GS, Pereira-Martins DA, Traina F, Fernandes PACM, Markus RP, Lucena-Araújo ARL, Machado Neto JA. PIP4K2A and PIP4K2C transcript levels are associated with cytogenetic risk and survival outcomes in acute myeloid leukemia [Internet]. Cancer Genetics. 2019 ; 233-234 56-66.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.cancergen.2019.04.002
Artigo de periodico
Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms (2019)
Lima, Keli Cristina de ; Carlos, Jorge Antonio Elias Godoy; Paiva, Raquel de Melo Alves ; Vicari, Hugo Passos; Santos, Fábio Pires de Souza ; Hamerschlak, Nelson ; Costa-Lotufo, Letícia Veras ; Traina, Fabiola ; Machado Neto, João Agostinho
Source: Scientific Reports. Unidades: ICB, FMRP
Subjects: FARMACOLOGIA, DOENÇAS DA MEDULA ÓSSEA, TRANSTORNOS MIELOPROLIFERATIVOS, ANTINEOPLÁSICOS, EXPRESSÃO GÊNICA, CITOESQUELETO, DANO AO DNA, PROLIFERAÇÃO CELULAR, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Keli Cristina de et al. Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms. Scientific Reports, v. 9, p. 9 , 2019Tradução . . Disponível em: https://doi.org/10.1038/s41598-019-46163-2. Acesso em: 06 nov. 2024.
APA
Lima, K. C. de, Carlos, J. A. E. G., Paiva, R. de M. A., Vicari, H. P., Santos, F. P. de S., Hamerschlak, N., et al. (2019). Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms. Scientific Reports, 9, 9 . doi:10.1038/s41598-019-46163-2
NLM
Lima KC de, Carlos JAEG, Paiva R de MA, Vicari HP, Santos FP de S, Hamerschlak N, Costa-Lotufo LV, Traina F, Machado Neto JA. Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms [Internet]. Scientific Reports. 2019 ; 9 9 .[citado 2024 nov. 06 ] Available from: https://doi.org/10.1038/s41598-019-46163-2
Vancouver
Lima KC de, Carlos JAEG, Paiva R de MA, Vicari HP, Santos FP de S, Hamerschlak N, Costa-Lotufo LV, Traina F, Machado Neto JA. Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms [Internet]. Scientific Reports. 2019 ; 9 9 .[citado 2024 nov. 06 ] Available from: https://doi.org/10.1038/s41598-019-46163-2

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Funding Agencies

Indexado em

Non normalized affiliation